➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
McKinsey
McKesson
AstraZeneca
Harvard Business School

Last Updated: June 18, 2021

DrugPatentWatch Database Preview

NOVOLOG INNOLET Drug Profile


Email this page to a colleague

« Back to Dashboard

Summary for Tradename: NOVOLOG INNOLET
Recent Litigation for NOVOLOG INNOLET

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.2017-03-03
Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.2017-03-02

See all NOVOLOG INNOLET litigation

Company Disclosures: US Patents for NOVOLOG INNOLET

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Novo Nordisk Inc NOVOLOG INNOLET insulin aspart recombinant INJECTABLE;SUBCUTANEOUS 020986 004 2001-01-19   Try Before You Buy Novo Nordisk A/S (Bagsvaerd, DK) 2014-04-08 DISCN company
Novo Nordisk Inc NOVOLOG INNOLET insulin aspart recombinant INJECTABLE;SUBCUTANEOUS 020986 004 2001-01-19   Try Before You Buy Novo Nordisk A/S (Bagsvaerd, DK) 2014-05-06 DISCN company
Novo Nordisk Inc NOVOLOG INNOLET insulin aspart recombinant INJECTABLE;SUBCUTANEOUS 020986 004 2001-01-19   Try Before You Buy Novo Nordisk A/S (Bagsvaerd, DK) 2014-12-02 DISCN company
Novo Nordisk Inc NOVOLOG INNOLET insulin aspart recombinant INJECTABLE;SUBCUTANEOUS 020986 004 2001-01-19   Try Before You Buy Novo Nordisk A/S (Bagsvaerd, DK) 2016-06-20 DISCN company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for NOVOLOG INNOLET

These patents were identified by searching patent claims

Supplementary Protection Certificates for NOVOLOG INNOLET

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
99C0044 Belgium   Try Before You Buy PRODUCT NAME: INSULIN-ASPART; NAT. REGISTRATION NO/DATE: EU/1/99/119/001 19990907; FIRST REGISTRATION: CH 55045 01 19990615
SZ 50/1999 Austria   Try Before You Buy PRODUCT NAME: INSULIN ASPART
C990042 Netherlands   Try Before You Buy PRODUCT NAME: INSULIN ASPART; REGISTRATION NO/DATE: EU/1/99/119/001 - EU/1/99/119/005 19990907
SPC/GB99/045 United Kingdom   Try Before You Buy SPC/GB99/045: 20060829, EXPIRES: 20110828
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Mallinckrodt
McKesson
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.